X iu Laigui is a Chinese pharmaceutical billionaire and the founder and chairman of the Xiuzheng Pharmaceutical Group. A former police officer, he founded the company in 1995 by acquiring a small, debt-ridden, state-owned drug factory. He has since built it into one of China's largest and most successful privately held pharmaceutical companies.
Xiuzheng has a vast and diversified portfolio of products, including a strong presence in both Western-style chemical drugs and traditional Chinese medicine. The company has a massive sales and distribution network across China, with a particular strength in the over-the-counter market. He is known for his hands-on leadership style and for building a powerful and well-known healthcare brand. His fortune is derived from his ownership of the massive, privately held pharmaceutical enterprise he created.
Advertisement
Xiu Laigui is a Chinese businessman, the self-made billionaire Founder and Executive Chairman of Yiling Pharmaceutical Co., Ltd. (SZSE: 002603), a major global manufacturer of Traditional Chinese Medicine (TCM) and pharmaceutical products. His career is rooted in medicine, TCM research, and entrepreneurial audacity.
Xiu holds a B.A. in Medicine (from a related source) and specialized in TCM. His philosophical approach centers on scale, technological excellence, and long-term commitment to integrating traditional and modern medicine (pioneering the modern TCM industrial model). He founded Yiling Pharmaceutical in 1992, recognizing the immense, untapped domestic and international demand for scientifically validated TCM products.
Xiu Laigui's strategic genius was his commitment to scientific validation of TCM. He founded Yiling Pharmaceutical in 1992, successfully building it into a global force by pioneering the industrial scale manufacturing of standardized TCM formulations. His structural contribution is immense: pioneering the modern, scale TCM industrial model that transformed the perception and production of traditional remedies. The company successfully executed its IPO on the SZSE.
He remains Executive Chairman, guiding the company's continuous expansion and technological modernization. His wealth is secured by the colossal, long-term, stable profitability of the global pharmaceutical and healthcare sector.
Advertisement
Founds Yiling Pharmaceutical Co., Ltd. (Founding).
Yiling Pharmaceutical executes its successful IPO on the SZSE (Financial Milestone).
Yiling's products gain prominence during the COVID-19 pandemic (Corporate Apex).
Continues as Founder and Executive Chairman, guiding the global pharmaceutical giant (Executive Oversight).
Xiu Laigui's wealth is concentrated in his founding equity and continued executive leadership of the publicly traded pharmaceutical giant, Yiling Pharmaceutical Co., Ltd. (SZSE: 002603), and his private investments.
Advertisement
Xiu Laigui's social impact stems from Yiling Pharmaceutical's role in providing essential medicines and TCM products, contributing significantly to public health and medical access in China. The company's products were widely used during the COVID-19 pandemic. His personal philanthropy supports various medical research and educational initiatives.
His personal philanthropy supports various community and educational initiatives.
Xiu Laigui maintains the professional, composed style of a corporate executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic reflects serious authority and intellectual depth, typical of a pioneer in the specialized pharmaceutical sector.
Residing in Shijiazhuang, China, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to industrial scale, technological innovation, and the long-term, stable growth of the healthcare supply chain.
Advertisement
No publicly available quotes.
Advertisement
+0.78% | +$39.70M
+9.58% | +$447.59M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content